Soft Tissue Market is estimated to be US$ 7.9 billion by 2030 with a CAGR of 7.3% during the forecast period

 

Soft Tissue comprises of muscles, ligaments, tendons, fibrous tissue, synovial membranes, skin, nerves and others which protect organs, enable movement and support bones in the body. Injury to the soft tissues can cause severe pain and also may stop the movement of the bones, which if left untreated can lead to chronic pain. The factors influencing soft tissue repair market growth are the growing number of patients suffering from sports-related injuries. Sprains, strains, contusions, tendinitis, and bursitis are some common injuries. Further, according to a United Nations report in 2015, the population of people aged 60 years and above is projected to grow by 56% and is expected to reach 1.4 billion by 2030. This in turn is expected to bolster the patient pool for joint replacement and soft tissue repair surgeries and in turn propel revenue growth of the market over the forecast period.

Region Analysis:

North America is expected to dominate the marketplace and account for around 32.2% share, whereas emerging economies which include India, China, and Brazil are expected to show off fast increase in the course of the forecast period. Rising geriatric populace and a growing quantity of trauma instances are expected to increase call for tender tissue repair products over the forecast period.

Further, Europe is expected to follow the Asia Pacific market with a CAGR of 7.2% among 2017 and 2025. Growing patient pool due to clinical tourism and a sturdy distribution network of the producers is expected to foster the market in Europe. Moreover, favorable healthcare guidelines can also be attributed to the growing demand over the forecast period.

Key Development:

·         In February 2021 - In2Bones Global, Inc. launched its Hercules Suture Anchor System and AlloAid Wedges for lower extremity surgeries in the United States and with the launch of Hercules Suture Anchor System, the company plans to accelerate sales in the sports medicine market.

·         In July 2021 -  Via Surgical, received United States Food and Drug Administration (FDA) 510(K) clearance for its TissueTak tendon anchor, which is the first closed-loop suture-based fixation system and a minimally-invasive surgical system for orthopedic surgeries for soft tissue repair of certain types of injuries.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/81  

Segmentation:

The global Soft Tissue Market accounted for US$ 3.9 billion in 2020 and is estimated to be US$ 7.9 billion by 2030 and is anticipated to register a CAGR of 7.3%. The global Soft Tissue Market is segmented based on product type, application, end users and region.

·         On the basis of type, the global Soft Tissue market is segmented into fixation products, tissue patch, and others.

·         On the basis of application, the global soft tissue market is segmented into breast reconstruction, dental and dural repair, hernia repair, orthopedic repair, vaginal prolapse repair, skin repair, cardiovascular surgery centers and others

·         On the basis of end users, the global soft tissue market is segmented into hospitals, clinics, ambulatory surgery centers and others.

·         On the basis of region, the global Soft Tissue Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Analysis:                                                                                                 

The key players operating in the global soft tissue market includes Life Cell Corporation, Organogenesis, Smith and Nephew, Johnson And Johnson, Covidien, Arthrex Inc, Integra Life Sciences Corporation, Stryker Medical Corporation, Wright Medical Technology, C. R. Bard, De Puy Synthes, and American Medical Systems.

 

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

 

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet...
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused ...
Read more

Humanized Liver Mice Model Market is estimated to be US$ 133.72 billion by 2030 with a CAGR of 5.30% during the forecast period

Image
Humanized Liver Mice Model Market   accounted for US$ 78.64 million in 2020 and is estimated to be US$ 133.72 million by 2030 and is anticipated to register a CAGR of 5.30%.  A lot of studies are underway to create novel humanized liver mouse models. Initially, liver mice models were created by implanting human liver cells or hepatic cancer cells into basic immune-deficient mice. The results, however, were inconsistent and unreliable. As a result, immune-deficient mice were developed, which spontaneously destroy the mice liver, allowing human liver cells to proliferate and replace it, resulting in stable humanized liver mice models. For example, a number of research projects are looking into using PPARalfa and AFC8-based mice models to develop humanized liver mice models. The report "Global Humanized Liver Mice Model Market, By Model (uPA-SCID, FRG KO Mice, TK-NOG Mice  and Other Models) By Application (Pharmacokinetics Studies, In-vivo Liver Toxicity Testing, Drug M...
Read more